RE: Chairman’s footprints….13 Oct 2022 09:23
Just going on figures published by GDR previously on the number of neonates that would require the AIHL test in the UK each year it seems a reasonable guess that those 6 hospitals in the north west in 6 months have run 2972 tests which are roughly £60 a pop. That’s really excellent for what is a relatively minor 10% of the population (that’s total guess work and could be way off). For 12 months you can reasonably double that Figure and then multiply that by 10 for the whole country perhaps. That amounts to an extremely decent chunk of income. Depending on how reliable these figures are…if we can work this out then a big pharma will too and know for sure that in two years time if this test is being used throughout the uk, US, EU and the Far East then there’s serious profit to be had from GDR’s test. But AIHL is only one of two which could be used globally so, together those tests and the Covid PoC kit (which would likely be thrown into a deal for nothing imo) GDR has to be worth a pretty penny or two. The Chairman Dr Ian Gilham will absolutely know this and already have lined up potential buyers. If a deal doesn’t come off then no problem, GDR goes ahead on its own. Just the one hurdle and that’s the cost of getting the US approvals. Once that is sorted GDR are all systems go. Just mho